Bionest appoints Sean X. Hu as managing director for North America
Mr. Hu brings more than six years of life science industry management consulting experience from IMS Management Consulting/SDG Life Sciences and AT Kearney. He was an early participant of the Human Genome Project and later involved in the International HapMap Project, both considered key scientific foundation of the personalized medicine field.
Trained and experienced in business as well as sciences, Mr. Hu brings both commercial and R&D perspectives to clients and has consulted extensively on broad personalized medicine strategy related issues. He was a representative on the FDA personalized medicine initiative consortium.
Earlier in his career and as part of his more than 17 years of experience in life science industries and academia, Mr. Hu worked for a number of life science companies of various sizes and industry segments.
Mr. Hu served as a business development professional at Illumina, a world leading genetic analysis/personalized medicine-enabling tool provider, at Bristol-Myers Squibb, a major pharma, in Sales and Marketing Services capacity, and at CuraGen, a genomic biopharma as a senior R&D scientist and operations manager. ■